Sign In
Get Clay Free →

Suggestions

    David Simmons

    Chief Executive Officer, BliNK Therapeutics Ltd

    David Simmons is a highly accomplished professional with a diverse educational background and extensive experience in the field of molecular biology and biochemistry.

    He holds a Doctor of Philosophy (Ph.D.) in Molecular Biology from The University of Edinburgh, a Master of Business Administration (M.B.A.) from The Open University, and a Bachelor's Degree in Biochemistry with first-class honors from the University of Cambridge.

    David has held prominent roles in various organizations, including Chief Scientific Officer at Cellzome, Vice President of Inflammation Discovery Research at Wyeth, Director of NCE Research at Celltech, and Group Director of Neuroscience Research at SmithKline Beecham.

    His professional journey also includes positions such as Staff Scientist and Head of the Cell Adhesion Laboratory at Cancer Research UK, Postdoctoral Research Fellow at Harvard Medical School in the Genetics Department, and MRC Postdoctoral Research Fellow at the University of Edinburgh.

    With a solid educational foundation and a wealth of leadership experience in both scientific and business domains, David's expertise covers a wide range of areas within the molecular biology and biochemistry fields.

    His contributions to various organizations have made a significant impact in the realm of scientific research and discovery.

    D
    Add to my network

    Location

    Stevenage, United Kingdom